Fig. 2From: Cerebralcare GranuleĀ® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functionsThe scheme of experiment and MWM test. a The scheme of experiment to determine the effect of CG on APP/PS1 memory loss. bāf MWM test was conducted on APP/PS1 mice. b The representative traces on the last day during acquisition phase. c Escape latency trend for six consecutive days. d Escape latency on the sixth day. e Times of passing through platform. f Time in the target quadrant. ^ Pā<ā0.05, ^^ Pā<ā0.01, ^^^ Pā<ā0.01 vs. WT group; * Pā<ā0.05, ** Pā<ā0.01, *** Pā<ā0.01 vs. Tg group; # Pā<ā0.05, ## Pā<ā0.001, ### Pā<ā0.001, vs. Mm group, & Pā<ā0.05, && Pā<ā0.001, &&& Pā<ā0.001, vs. CG group (nā=ā10)Back to article page